siRNA
HORIZON DISCOVERY BIOSCIENCES LIMITED ACCELL HUMAN ELF3 SIRNA SMARTP
Accell Human ELF3 siRNASMARTpool 20nmol
HORIZON DISCOVERY BIOSCIENCES LIMITED OTP MOUSE SOCS1 12703 SIRNA
NC3412893 OTP MOUSE SOCS1 12703 SIRNA
HORIZON DISCOVERY BIOSCIENCES LIMITED SMARTPOOL SIRNA REAGENT 10NMOL
NC3847169 SMARTPOOL SIRNA REAGENT 10NMOL
Sigma Aldrich Fine Chemicals Biosciences PI3 Kinase (p110α/p85α) Protein
PI3 Kinase (p110α/p85α) Protein | Active complex of N-terminal His6-tagged recombinant full-length human p110α & untagged, recombinant, full length, human p85α. For use in Kinase Assays, 20ug
HORIZON DISCOVERY BIOSCIENCES LIMITED ON-TARGETPLUS HUMAN HMGCS1 31
NC3654441 ON-TARGETPLUS HUMAN HMGCS1 31
Bioss KD-Validated ACAP2 Rabbit Reco
ArfGAP With Coiled-Coil Ankyrin Repeat And PH Domains 2 Primary Antibody Unconjugated Public Immunogen Range 650-720/778 Host Species Rabbit Target Species Human Mouse Rat Clonality Monoclonal Applications WB FCM IC Concentration Lot dependent Size 50 ul Storage Buffer Supplied in PBS (pH 7 4) containing 50% glycerol and 0 02% sodium azide
Bioss KD-Validated ACBD3 Rabbit Reco
Acyl-CoA Binding Domain Containing 3 Primary Antibody Unconjugated Public Immunogen Range 1-61/528 Host Species Rabbit Target Species Human Clonality Monoclonal Applications WB FCM IC Concentration Lot dependent Size 50 ul Storage Buffer Supplied in PBS (pH 7 4) containing 50% glycerol and 0 02% sodium azide
HORIZON DISCOVERY BIOSCIENCES LIMITED OTP MOUSE NKX2-3 18089 SIRNA
NC2584127 OTP MOUSE NKX2-3 18089 SIRNA
Bioss KD-Validated ATP5B Rabbit Reco
ATP Synthase F1 Subunit Beta Primary Antibody Unconjugated Public Immunogen Range 140-200/529 Host Species Rabbit Target Species Human Mouse Rat Clonality Monoclonal Applications WB FCM IC Concentration Lot dependent Size 50 ul Storage Buffer Supplied in PBS (pH 7 4) containing 50% glycerol and 0 02% sodium azide
HORIZON DISCOVERY BIOSCIENCES LIMITED ON-TARGETplus Non-targeting Control siRNAs #2, 5nmol
ON-TARGETplus Non-targeting Control siRNAs are the ideal negative control for RNAi experiments in human, mouse, and rat cells. ON-TARGETplus Non-targeting siRNAs were designed to leverage seed-region optimization and patented ON-TARGETplus modification patterns to have fewer off-targets than traditionally designed, unmodified negative control siRNAs. Changes in mRNA or protein levels in cells treated with these controls reflect a baseline cellular response that can be compared to the levels in cells treated with target-specific siRNA.